| Primary |
| Product Used For Unknown Indication |
39.3% |
| Drug Use For Unknown Indication |
25.7% |
| Schizophrenia |
5.4% |
| Psychotic Disorder |
4.5% |
| Agitation |
2.7% |
| Bipolar Disorder |
2.6% |
| Self Injurious Behaviour |
2.5% |
| Depression |
2.1% |
| Ill-defined Disorder |
2.1% |
| Drug Exposure During Pregnancy |
1.8% |
| Hypertension |
1.6% |
| Anxiety |
1.6% |
| Schizophrenia, Paranoid Type |
1.6% |
| Abnormal Behaviour |
1.2% |
| Schizoaffective Disorder |
1.2% |
| Pain |
0.9% |
| Delirium |
0.9% |
| Accidental Exposure |
0.9% |
| Insomnia |
0.8% |
| Foetal Exposure During Pregnancy |
0.8% |
|
| Self Injurious Behaviour |
14.1% |
| Suicide Attempt |
11.0% |
| Tremor |
9.7% |
| Somnolence |
9.5% |
| Weight Increased |
7.3% |
| Sopor |
5.6% |
| Parkinsonism |
4.4% |
| Sluggishness |
4.4% |
| Tachycardia |
4.3% |
| Vomiting |
3.8% |
| Weight Decreased |
3.7% |
| Incorrect Route Of Drug Administration |
3.3% |
| Tardive Dyskinesia |
3.0% |
| Death |
2.6% |
| Rhabdomyolysis |
2.5% |
| Extrapyramidal Disorder |
2.2% |
| Urinary Retention |
2.2% |
| Neuroleptic Malignant Syndrome |
2.1% |
| Overdose |
2.1% |
| Psychotic Disorder |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
33.0% |
| Drug Use For Unknown Indication |
20.0% |
| Schizophrenia |
8.1% |
| Bipolar Disorder |
4.4% |
| Schizoaffective Disorder |
4.2% |
| Psychotic Disorder |
4.1% |
| Depression |
3.1% |
| Agitation |
2.9% |
| Anxiety |
2.8% |
| Hypertension |
2.4% |
| Schizophrenia, Paranoid Type |
2.4% |
| Mania |
1.9% |
| Pain |
1.7% |
| Ill-defined Disorder |
1.5% |
| Insomnia |
1.4% |
| Restlessness |
1.4% |
| Hallucination |
1.3% |
| Dementia Alzheimer's Type |
1.1% |
| Aggression |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
|
| Weight Increased |
11.4% |
| Vomiting |
8.4% |
| Pleurothotonus |
8.2% |
| Somnolence |
7.1% |
| Parkinsonism |
6.4% |
| Tardive Dyskinesia |
6.0% |
| Suicide Attempt |
5.5% |
| Psychotic Disorder |
5.1% |
| Tremor |
5.1% |
| Toxic Epidermal Necrolysis |
4.2% |
| Tachycardia |
3.8% |
| Restlessness |
3.6% |
| Pneumonia |
3.4% |
| Death |
3.3% |
| Weight Decreased |
3.3% |
| Fall |
3.2% |
| Respiratory Failure |
3.2% |
| Self Injurious Behaviour |
3.2% |
| Schizophrenia |
2.9% |
| Sedation |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.7% |
| Schizophrenia |
11.6% |
| Depression |
11.5% |
| Bipolar Disorder |
10.4% |
| Drug Use For Unknown Indication |
9.7% |
| Anxiety |
6.1% |
| Pain |
4.3% |
| Psychotic Disorder |
3.8% |
| Hypertension |
3.8% |
| Agitation |
3.2% |
| Insomnia |
2.8% |
| Sleep Disorder |
2.7% |
| Mental Disorder |
2.5% |
| Diabetes Mellitus |
2.3% |
| Schizoaffective Disorder |
2.1% |
| Lower Limb Fracture |
1.6% |
| Nausea |
1.4% |
| Schizophrenia, Paranoid Type |
1.3% |
| Affective Disorder |
1.2% |
| Prophylaxis |
1.1% |
|
| Type 2 Diabetes Mellitus |
33.4% |
| Weight Increased |
10.9% |
| Pancreatitis |
7.1% |
| Withdrawal Syndrome |
5.5% |
| Tardive Dyskinesia |
5.3% |
| Vomiting |
5.1% |
| Diabetes Mellitus |
4.5% |
| Weight Decreased |
4.0% |
| Urinary Tract Infection |
3.2% |
| Type 1 Diabetes Mellitus |
2.4% |
| Death |
2.3% |
| Obesity |
2.2% |
| Tremor |
2.1% |
| Granulocytopenia |
2.0% |
| Overdose |
1.8% |
| Diabetic Coma |
1.8% |
| Diabetic Ketoacidosis |
1.7% |
| Suicide Attempt |
1.7% |
| Gastric Ulcer |
1.6% |
| Suicidal Ideation |
1.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
21.6% |
| Bipolar Disorder |
16.8% |
| Product Used For Unknown Indication |
15.7% |
| Asthma |
8.2% |
| Schizophrenia |
5.9% |
| Hypertension |
5.7% |
| Headache |
5.5% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Gout |
2.7% |
| Depression |
2.4% |
| Blood Cholesterol Abnormal |
2.2% |
| Restlessness |
2.2% |
| Schizoaffective Disorder |
1.8% |
| Extrapyramidal Disorder |
1.6% |
| Anaesthetic Premedication |
1.1% |
| Restless Legs Syndrome |
1.1% |
| Psychotic Disorder |
0.9% |
| Dyspnoea |
0.7% |
| Hallucination |
0.7% |
| Anxiety |
0.4% |
|
| Drug Interaction |
20.5% |
| Vomiting |
14.5% |
| Fall |
7.2% |
| Infectious Peritonitis |
7.2% |
| Micturition Disorder |
7.2% |
| Thrombocytopenia |
6.0% |
| Abdominal Distension |
3.6% |
| Nausea |
3.6% |
| Sleep Apnoea Syndrome |
3.6% |
| Verbigeration |
3.6% |
| Vision Blurred |
3.6% |
| Altered State Of Consciousness |
2.4% |
| Death |
2.4% |
| Somnolence |
2.4% |
| Sudden Death |
2.4% |
| Tremor |
2.4% |
| Urinary Incontinence |
2.4% |
| Ventricular Fibrillation |
2.4% |
| Cardiac Arrest |
1.2% |
| Coma |
1.2% |
|
